Page last updated: 2024-10-28

hydroxyurea and Aseptic Necrosis of Femur Head

hydroxyurea has been researched along with Aseptic Necrosis of Femur Head in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Sickle cell disease is characterized by phenotypic heterogeneity and many genetic modifiers have been identified with elevated Hb F being the most recognized ameliorating factor."1.37Limitations of Hb F as a phenotypic modifier in sickle cell disease: study of Kuwaiti Arab patients. ( Adekile, AD, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adekile, AD2
Gupta, R1
Al-Khayat, A1
Mohammed, A1
Atyani, S1
Thomas, D1
Mahadeo, KM1
Oyeku, S1
Taragin, B1
Rajpathak, SN1
Moody, K1
Santizo, R1
Driscoll, MC1

Other Studies

3 other studies available for hydroxyurea and Aseptic Necrosis of Femur Head

ArticleYear
Risk of avascular necrosis of the femoral head in children with sickle cell disease on hydroxyurea: MRI evaluation.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:2

    Topics: Adolescent; Anemia, Sickle Cell; Antisickling Agents; Child; Female; Femur Head Necrosis; Humans; Hy

2019
Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease.
    American journal of hematology, 2011, Volume: 86, Issue:9

    Topics: Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Child; Cohort Studies; Cross-Sectional

2011
Limitations of Hb F as a phenotypic modifier in sickle cell disease: study of Kuwaiti Arab patients.
    Hemoglobin, 2011, Volume: 35, Issue:5-6

    Topics: alpha-Thalassemia; Anemia, Sickle Cell; Arabs; Femur Head Necrosis; Fetal Hemoglobin; Genetic Associ

2011